138
Views
14
CrossRef citations to date
0
Altmetric
Review Article

Drug therapy of dementia in elderly patients. A review

, &
Pages 71-77 | Accepted 02 Nov 2004, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cecilia Holmstrand, Ingalill Rahm Hallberg, Kai Saks, Helena Leino-Kilpi, Anna Renom Guiteras, Hilde Verbeek, Adelaida Zabalegui, Caroline Sutcliffe & Connie Lethin. (2021) Associated factors of suicidal ideation among older persons with dementia living at home in eight European countries. Aging & Mental Health 25:9, pages 1730-1739.
Read now

Articles from other publishers (13)

Débora Priscila de Campos, Neila Márcia Silva-Barcellos, Tamires Guedes Caldeira, Wagner da Nova Mussel, Virgínia Silveira & Jacqueline de Souza. (2022) Donepezil Hydrochloride BCS Class Ambiguity: Relevant Aspects to be Considered in Drug Classification. Journal of Pharmaceutical Sciences 111:11, pages 3064-3074.
Crossref
Haya Hussain, Shujaat Ahmad, Syed Wadood Ali Shah, Abid Ullah, Niaz Ali, Mazen Almehmadi, Manzoor Ahmad, Atif Ali Khan Khalil, Syed Babar Jamal, Hanif Ahmad & Mustafa Halawi. (2022) Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. Molecules 27:8, pages 2468.
Crossref
Haya Hussain, Shujaat Ahmad, Syed Wadood Ali Shah, Mehreen Ghias, Abid Ullah, Shafiq Ur Rahman, Zul Kamal, Farman Ali Khan, Nasir Mehmood Khan, Juma Muhammad, Mazen Almehmadi, Osama Abdulaziz & Saad Alghamdi. (2021) Neuroprotective Potential of Synthetic Mono-Carbonyl Curcumin Analogs Assessed by Molecular Docking Studies. Molecules 26:23, pages 7168.
Crossref
Li-Fen Wu & Malcolm Koo. (2016) Randomized controlled trial of a six-week spiritual reminiscence intervention on hope, life satisfaction, and spiritual well-being in elderly with mild and moderate dementia. International Journal of Geriatric Psychiatry 31:2, pages 120-127.
Crossref
Kristina Johnell & Johan Fastbom. (2008) Concurrent Use of Anticholinergic Drugs and Cholinesterase Inhibitors. Drugs & Aging 25:10, pages 871-877.
Crossref
Hua Yu, Wen-Ming Li, Kelvin K.W. Kan, Jason M.K. Ho, Paul R. Carlier, Yuan-Ping Pang, Zhe-Ming Gu, Zuo Zhong, Kelvin Chan, Yi-Tao Wang & Yi-Fan Han. (2008) The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine. Journal of Pharmaceutical and Biomedical Analysis 46:1, pages 75-81.
Crossref
Rita MorettiPaola TorreRodolfo M AntonelloCristina VilottiGilberto Pizzolato. (2007) New treatment options for vascular dementia. Aging Health 3:2, pages 209-222.
Crossref
Zhong Jin. (2007) Amaryllidaceae and Sceletium alkaloids. Natural Product Reports 24:4, pages 886.
Crossref
Martin R. Farlow. (2006) Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease. Mayo Clinic Proceedings 81:10, pages 1350-1358.
Crossref
Vee P. Prasher & Dale Lawrence. (2006) Psychiatric morbidity in adults with Down syndrome. Psychiatry 5:9, pages 316-319.
Crossref
Koji FUKUDA & Makoto TANAKA. (2006) Influence of the FDA Talk Paper upon the use of atypical antipsychotics for psychotic symptoms in older patients with dementia in Japan. Psychogeriatrics 6:2, pages 81-86.
Crossref
Zhe Xiong, Chao Liu, Fang Wang, Cailian Li, Wei Wang, Jianzhi Wang & Jianguo Chen. (2006) Protective Effects of Breviscapine on Ischemic Vascular Dementia in Rats. Biological and Pharmaceutical Bulletin 29:9, pages 1880-1885.
Crossref
. (2005) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 20:10, pages 1005-1012.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.